Global Balloon Catheters Market - 2022-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	180 Pages	DataM Intelligence 4Market Research LLP	October, 2022	DTAM17475810

Best Price Guarantee
Price	from $4,350
Length	180 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	October, 2022
SKU	DTAM17475810

Global Balloon Catheters Market - 2022-2029

Market Overview

Balloon Catheters Market size was valued US$ 4.58 billion in 2021 and is estimated to reach US$ 8.65 billion by 2029, growing at a CAGR of 8.7% during the forecast period (2022-2029).

The balloon catheter is a flexible and delicate catheter device type with a balloon-like, attached at its tip. This balloon can be inflated or deflated when the catheter is in place to enlarge or create a passageway. Balloon Catheters are primarily used to treat heart-related diseases, specifically coronary heart disease caused due to diabetes, high cholesterol levels in blood, and high blood pressure.

Market Dynamics

The growth of the market is majorly driven by increasing incidences of cardiac diseases, the rising geriatric population, growing demand for minimally invasive surgery, and increasing government initiatives like favorable reimbursement policies.

Increasing incidences of cardiac diseases coupled with technological advancements are expected to drive market growth

According to Coronary Artery Disease among Asian Indians (CADI) Research Foundation, around 60,000 coronary artery bypass surgery performed every year in India. Asian Indians constitute a fifth of the global population and have been noted to have the highest coronary artery disease (CAD) rates. The number of coronary artery bypass surgeries will keep rising due to the increasing geriatric population with diabetes and high blood cholesterol levels.

Furthermore, technological advancements have resulted in the developing of innovative products, giving better outcomes. For instance, in April 2021, Cardiovascular Systems launched innovative peripheral balloon catheters for complex lesions. In addition, companies are investing in research on new technologies and their safety studies and receiving support from the governments for analysis. For instance, in April 2022, Terumo Corporation released the first patient enrolment for the study on its latest bobby balloon guide catheter.

The high cost associated with the treatment is one of the major factors hindering the growth of the market

The expensive cost of sophisticated catheters could limit industry expansion. In addition, a growing proportion of patients undergoing catheterization need innovative catheters because they have chronic and cardiovascular disorders like urine bladder, renal failure, and coronary heart disease. However, the adoption rate of catheters may decline throughout low-income countries due to the expensive catheterization operations for these disorders.

The high price of these gadgets and necessary accessories could limit market expansion. In addition, market growth in underdeveloped nations with relatively low-income levels may be constrained because of the high costs involved with catheterization procedures. As a result, it might be challenging for middle-income and low-income countries to adopt such expensive goods. Therefore, the high price of these advanced devices could restrain the expansion of the catheter market over the estimated year.

COVID-19 Impact Analysis

Due to on-hold services, such as treatment, diagnostic, and surgical services, to stop the spread of COVID-19 disease, it is projected that the COVID-19 epidemic will have a short-term negative impact on the growth of the global catheters industry. Jordan implemented a severe COVID-19-related lockout, according to the National Library of Medicine. Cardiovascular catheterization procedure volumes drastically decreased during the rigorous lockdown and gradually increased following a partial relaxation of the lockdown. However, as the government and healthcare organisations continue to enhance medical care for COVID-19 patients, catheters will be utilised more frequently in hospitals. Catheters are being used to treat the patients whose COVID-19 diagnoses were verified.

Industry Analysis

The global balloon catheters market provides in-depth analysis of the market based on various industry factors such as porter’s five forces, regulatory analysis, reimbursement analysis, supply chain analysis, pricing analysis, technological advancements etc.

Segment Analysis

Drug-eluting balloon catheters segment is expected to hold the largest market share in global balloon catheters market

The segment is growing due to the growing usage of a drug-eluting balloons in the treatment of peripheral artery diseases as these devices are easy to use and the treatment shows improved patency rate as compared to that of standard PTA balloons. In addition, the growth of the peripheral drug-eluting balloon segment is attributed to the increasing development in these devices by major players.

The coronary drug-eluting balloon segment is anticipated to register an above-average growth rate during the forecast period despite the predominant use of drug-eluting stents in coronary interventions. A rise in preference for a drug-eluting balloons for coronary interventions has been observed among physicians as these devices have the potential to eradicate the risk of stent failure and show higher efficiency than drug-eluting stents. Additionally, anticipated product launches by Boston Scientific and Concept, Medical, Inc. are likely to drive the coronary drug-eluting balloon segment during the forecast period. For instance, In 2021, Medtronic plc launched the Prevail drug coated balloon (DCB) Catheter in Europe for treating coronary artery disease.

Geographical Analysis

North America region holds the largest market share in the global balloon catheters market

This large revenue share is mainly due to the rising prevalence of urological illnesses, renal failure, and the abundance of highly qualified surgeons, among other things. For instance, every seventh adult in the United States, or more than 37 million people, is projected to have chronic kidney disease, according to estimates from the Centers for Disease Control and Prevention (CDC). It is anticipated that the rising prevalence of diseases would increase the demand for catheterization operations, which employ these devices. The American Urological Association (AUANET) estimates that there will be 13,352 urologists working full-time in the United States in 2020. Additionally, it is anticipated that rising cardiac catheterization hospitalizations will promote market expansion in the nation. For instance, the NCBI estimates that more than 1,000,000 cardiac catheterization operations are carried out each year in the United States. Major players' presence in the area will also increase consumer demand and adoption rates for the products. Therefore, it is anticipated that the aforementioned causes will increase demand for catheterization procedures.

Competitive Landscape

Some of the key players in the global Balloon Catheters market are Biomerics, Boston Scientific Corporation, A.V medical, Teleflex Medical, Johnson & Johnson, Medtronic, Inc, MicroPort Scientific Corporation, Vascular Solutions, Inc, Abbott Laboratories, BIOTRONIK SE & Co. KG, Nordson.

Global Balloon Catheters Market – Key Companies to Watch

Medtronic Plc:

Overview: Medtronic plc is an American company that operates in U.S. and manufactures and markets medical device headquarters in Minneapolis, US. It is operational in around 140 countries and 90,000 people are employed there.

Product Portfolio: EUPHORA SEMICOMPLIANT BALLOON CATHETER

The global balloon catheters market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary: 3.1. Market Snippet by Product Type; 3.2. Market Snippet by Material Type; 3.3. Market Snippet by Disease Indication; 3.4. Market Snippet by End User; 3.5. Market Snippet by Region
4. Market Dynamics: 4.1. Market Impacting Factors; 4.2. Drivers; 4.2.1. Increasing incidences of cardiac diseases coupled with technological advancements; 4.3. Restraints; 4.3.1. The high cost associated with the treatment; 4.4. Opportunity; 4.5. Impact Analysis
5. Industry Analysis: 5.1. Porter's Five Forces Analysis; 5.2. Regulatory Analysis; 5.3. Supply Chain Analysis; 5.4. Pricing Analysis; 5.5. Epidemiology; 5.6. Reimbursement Analysis; 5.7. Unmet Needs
6. By Product type: 6.1. Introduction; 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 6.1.2. Market Attractiveness Index, By Product Type; 6.2. Normal balloon catheter*; 6.2.1. Introduction; 6.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029; 6.3. Cutting balloon catheter; 6.4. Scoring balloon catheter; 6.5. Drug-eluting balloon catheter; 6.6. Stent graft balloon catheter
7. By Material type: 7.1. Introduction; 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 7.1.2. Market Attractiveness Index, By Material Type; 7.2. Polyurethane*; 7.2.1. Introduction; 7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029; 7.3. Nylon; 7.4. Others
8. By Disease Indication: 8.1. Introduction; 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 8.1.2. Market Attractiveness Index, By Disease Indication; 8.2. Coronary artery disease*; 8.2.1. Introduction; 8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029; 8.3. Peripheral vascular disease
9. By End-User: 9.1. Introduction; 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users Segment; 9.1.2. Market Attractiveness Index, By End-Users Segment; 9.2. Ambulatory Surgical Centers *; 9.2.1. Introduction; 9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029; 9.3. Hospitals; 9.4. Cardiac Catheterization Laboratories; 9.5. Others
10. By Region: 10.1. Introduction; 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region; 10.1.2. Market Attractiveness Index, By Region; 10.2. North America; 10.2.1. Introduction; 10.2.2. Key Region-Specific Dynamics; 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User; 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country; 10.2.7.1. The U.S.; 10.2.7.2. Canada; 10.2.7.3. Mexico; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Key Region-Specific Dynamics; 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User; 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country; 10.3.7.1. Germany; 10.3.7.2. The U.K.; 10.3.7.3. France; 10.3.7.4. Italy; 10.3.7.5. Spain; 10.3.7.6. Rest of Europe; 10.4. South America; 10.4.1. Introduction; 10.4.2. Key Region-Specific Dynamics; 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User; 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country; 10.4.7.1. Brazil; 10.4.7.2. Argentina; 10.4.7.3. Rest of South America; 10.5. Asia Pacific; 10.5.1. Introduction; 10.5.2. Key Region-Specific Dynamics; 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User; 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country; 10.5.7.1. China; 10.5.7.2. India; 10.5.7.3. Japan; 10.5.7.4. Australia; 10.5.7.5. Rest of Asia Pacific; 10.6. The Middle East and Africa; 10.6.1. Introduction; 10.6.2. Key Region-Specific Dynamics; 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type; 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type; 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication; 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape: 11.1. Competitive Scenario; 11.2. Market Positioning/Share Analysis; 11.3. Mergers and Acquisitions Analysis
12. Company Profiles: 12.1. Medtronic*; 12.1.1. Company Overview; 12.1.2. Product Portfolio and Description; 12.1.3. Key Highlights; 12.1.4. Financial Overview; 12.2. Boston Scientific Corporation; 12.3. Biomerics; 12.4. Teleflex Medical; 12.5. A.V medical; 12.6. Vascular Solutions, Inc; 12.7. Abbott Laboratories; 12.8. BIOTRONIK SE & Co. KG; 12.9. Johnson & Johnson; 12.10. MicroPort Scientific Corporation; 12.11. Nordson
13. Global Balloon Catheters Market – DataM: 13.1. Appendix; 13.2. About Us and Services; 13.3. Contact Us